#China #Jinan #Legal Affairs #Angelalign #Premolar Extraction

Angelalign Technology Appeals Court Decision in China

Overview

Angelalign Technology Inc. (6699.HK), a leading provider of digital orthodontic solutions, has announced its decision to appeal a recent ruling by the Intermediate People's Court of Jinan, China. The ruling, which orders Angel's Chinese subsidiaries to cease using their biomechanical simulation system, masterForce, and digital design system, ATreat, affects the company’s ability to generate solutions for extracting premolars—specifically the A7 and A7 Speed models.

Despite this preliminary decision, Angelalign reassures its customers that there is no immediate impact on their services. The ruling is limited to China and has yet to come into effect, pending the outcome of the appeal.

Details of the Case

On August 10, 2026, the Jinan court issued its first-instance ruling, prompting Angelalign to express confidence in their legal position. The company maintains that the A7 premolar extraction solutions do not violate any existing patents. A history of successful patent litigations against the claimant strengthens their stance. In different jurisdictions worldwide, Angelalign has defended its intellectual property and fair competition practices vigorously.

“The court's decision is confined to China, and it has not caused any immediate impact on our clients even within the country,” stated Fox Hu, CEO of Angelalign Technology. “We are encouraged by the growing support from orthodontists globally for our professional solutions. We expect to prevail in this appeal, backed by our track record of winning similar cases.”

The competitive landscape highlights a strong lineage of legal challenges. On May 12, 2026, the Local Division of Düsseldorf (Germany) of the Unified Patent Court rejected the claimant's request for a preliminary injunction against Angelalign for its premolar extraction solutions. The claimant opted not to appeal this ruling, which now stands firm. Interestingly, the European patent involved shares a familial relation with the Chinese patent under scrutiny in Jinan, emphasizing the interconnectedness of global patent laws.

In an earlier context, the Zhengzhou Intermediate People's Court of China ruled favorably for Angelalign on June 26, 2026, dismissing two infringement lawsuits filed by the claimant. The legal dispute continues as the claimant files an appeal against these decisions.

Commitment to Innovation

Angelalign stands by its commitment to intellectual property rights. With over 20 years of innovation in the orthodontic field, the company is recognized by leading orthodontists—including competitors—as a pioneer in addressing complex orthodontic cases. Angelalign's product offerings, which include angelButton™ and the A6 Mandibular Advancement System, set the benchmark for technological innovation within the industry.

With a market capitalization of $2 billion, healthy profitability, and a robust global network, Angelalign is positioned to maintain its long-term partnerships with orthodontists and deliver exceptional clinical outcomes. The ongoing litigation marks a chapter in a larger narrative between Angelalign and Align Technology Inc. (ALGN), which continues to allege patent infringement, a claim that Angelalign firmly denies.

Conclusion

For further information on the legal proceedings surrounding Angelalign Technology Inc., visit Angelalign Legal Proceedings. Since its establishment in 2003, Angelalign has become synonymous with digital orthodontic solutions, boasting over 2 million smiles transformed worldwide. The company’s commitment to creating comprehensive solutions caters to dental professionals and patients alike, as it expands its reach in the global market, which now includes over 60 countries and regions.

With momentum continuing to build, Angelalign remains a formidable entity in the orthodontic market as they navigate these challenges, focusing on innovation and customer satisfaction.